会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • MODIFIED ERYTHROPOIETIN TO WHICH WATER-SOLUBLE LONG-CHAIN MOLECULE IS ADDED
    • 添加了可溶性长链分子的改良的红细胞膜蛋白
    • US20120264687A1
    • 2012-10-18
    • US13395534
    • 2010-09-15
    • Nobutaka TaniToshihide FujiiHiroyuki WatanabeHirofumi Maeda
    • Nobutaka TaniToshihide FujiiHiroyuki WatanabeHirofumi Maeda
    • A61K38/18A61P7/06
    • A61K9/0019A61K38/1816A61K47/60
    • An object of the invention is to provide a pharmaceutical composition that contains erythropoietin as the active ingredient and has, when administered in humans and/or animals, a hematopoietic effect that lasts for not less than seven days. The invention provides a pharmaceutical composition containing, in an amount equal to not less than 50% of the total erythropoietin, erythropoietin to which two or more water-soluble long-chain molecules are added. The invention also provides a pharmaceutical composition containing erythropoietin to which a water-soluble long-chain molecule is added, wherein the water-soluble long-chain molecule has a molecular weight of not less than 30 kDa. The invention further provides a pharmaceutical composition containing erythropoietin to which a water-soluble long-chain molecule is added, wherein the water-soluble long-chain molecule has a branched chain.
    • 本发明的目的是提供一种含有促红细胞生成素作为活性成分并且在人和/或动物中施用时持续不少于7天的造血作用的药物组合物。 本发明提供一种药物组合物,其含量等于不少于总促红细胞生成素的50%,红细胞生成素,其中加入了两种或更多种水溶性长链分子。 本发明还提供含有促红细胞生成素的药物组合物,其中加入水溶性长链分子,其中水溶性长链分子的分子量不小于30kDa。 本发明还提供含有促红细胞生成素的药物组合物,其中加入水溶性长链分子,其中所述水溶性长链分子具有支链。
    • 5. 发明授权
    • Adsorbent for serum amyloid protein
    • 血清淀粉样蛋白用吸附剂
    • US6037458A
    • 2000-03-14
    • US948470
    • 1992-09-22
    • Fumiyasu HiraiNobutaka Tani
    • Fumiyasu HiraiNobutaka Tani
    • A61M1/34A61M1/36B01D15/00B01J20/32A23J1/00A61K35/14A61M37/00
    • A61M1/3486B01D15/00B01J20/3204B01J20/321B01J20/3212B01J20/3219B01J20/3248B01J20/3251B01J20/3253B01J20/3274B01J20/328A61M1/3679
    • An adsorbent for a serum amyloid protein, which comprises a water-insoluble carrier and either a compound selected from the group consisting of a compound having an anionic functional group, a polyanionic compound having more than one anionic functional groups, aniline and an aniline derivative, said compound being immobilized onto said carrier, or a group of the formula: --NR.sup.1 R.sup.2, wherein R.sup.1 is hydrogen atom, methyl group or ethyl group, and R.sup.2 is an atomic group satisfying that the value of log P, in which P is a distribution coefficient in a water-octanol system, of a compound of the formula: R.sup.2 H is from 0 to 3.2, said group being bonded to said carrier, and a method for removing a serum amyloid protein from body fluid through a removing apparatus using the above adsorbent. According to the present invention, SA proteins, particularly SAA proteins and SAP proteins can be selectively removed from body fluid without decreasing HDL largely. Besides, the adsorbent can be provided at a low cost.
    • 一种血清淀粉样蛋白的吸附剂,其包含水不溶性载体和选自具有阴离子官能团的化合物,具有多于一个阴离子官能团的聚阴离子化合物,苯胺和苯胺衍生物, 所述化合物被固定在所述载体上,或下式-NR 1 R 2基团,其中R 1是氢原子,甲基或乙基,R 2是满足log P值的原子团,其中P是分布 在水 - 辛醇体系中,式R2H的化合物的系数为0至3.2,所述基团键合到所述载体上,以及通过使用上述吸附剂的去除装置从体液中除去血清淀粉样蛋白的方法 。 根据本发明,SA蛋白质,特别是SAA蛋白质和SAP蛋白质可以选择性地从体液中除去而不会大大降低HDL。 此外,可以以低成本提供吸附剂。
    • 10. 发明授权
    • Apparatus for purifying blood
    • 血液净化装置
    • US4609461A
    • 1986-09-02
    • US638084
    • 1984-08-06
    • Satoshi TakataNobutaka Tani
    • Satoshi TakataNobutaka Tani
    • A61M1/22A61M1/34A61M1/36B01D13/00
    • A61M1/3472A61M1/3427A61M1/3679A61M1/3687
    • An apparatus for purifying blood which is able to separate blood into plasma and blood rich in blood cells, to purify the separated plasma and to mix the purified plasma into the blood stream simultaneously by itself.The apparatus has two parts, i.e. a blood flowing system in which the blood is separated by means of porous hollow fibers provided in a container and the purified plasma is mixed into the blood stream through the hollow fibers, and a plasma flowing path in which the separated plasma is circulated and purified at a plasma purifying device provided on the way of the path.The apparatus has a simple structure and can be operated without any specific cares and difficulty. The apparatus is free from any problems, for instance, hemolysis, fiber blockage, mixing of the purifier particles into blood, and the like.
    • 一种用于净化血液的装置,其能够将血液分离成血浆和富含血细胞的血液,以纯化分离的血浆并将纯化的血浆自身同时混合到血液中。 该装置具有两部分,即血液流动系统,其中通过设置在容器中的多孔中空纤维将血液分离,并且将纯化的血浆通过中空纤维混入血液流中,其中等离子体流动路径 分离的等离子体在路径路径上设置的等离子体净化装置中循环和净化。 该装置具有简单的结构,可以在没有任何具体的关心和困难的情况下操作。 该装置没有任何问题,例如溶血,纤维堵塞,将净化剂颗粒混合到血液中等。